• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 TITANIUM LOW-PROFILE IMPLANTABLE PORT, BROVIAC SINGLE-LUMEN, 6.6F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 TITANIUM LOW-PROFILE IMPLANTABLE PORT, BROVIAC SINGLE-LUMEN, 6.6F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Model Number 0602190
Device Problems Entrapment of Device (1212); Fracture (1260); Difficult to Remove (1528); Material Separation (1562)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/16/2023
Event Type  malfunction  
Event Description
It was reported that approximately three years and one month post-port placement, the port allegedly broke away from the catheter during the attempt to remove the device.It was further reported that the port was easily dissected free of the capsule.It was also reported that the catheter was allegedly fixed at the subclavian vein entry site and was dissected free of surrounding tissue down to the vein under the clavicle.However, the external aspect of the catheter was noted to be changed from smooth to textured, likely related to calcifications, adhesion, or ingrowth within the vein.Reportedly, the catheter was unable to be pulled out with vein tenting upon traction, and it was decided to leave the internal catheter in place due to the risk of vein injury or hemorrhage.The external catheter and the subcutaneous port were removed.There was no reported patient injury.
 
Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.Expiry date: 04/2023.Section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event Description
It was reported that approximately three years and one month post-port placement, the port allegedly broke away from the catheter during the attempt to remove the device.It was further reported that the port was easily dissected free of the capsule.It was also reported that the catheter was allegedly fixed at the subclavian vein entry site and was dissected free of surrounding tissue down to the vein under the clavicle.However, the external aspect of the catheter was noted to be changed from smooth to textured, likely related to calcifications, adhesion, or ingrowth within the vein.Reportedly, the catheter was unable to be pulled out with vein tenting upon traction, and it was decided to leave the internal catheter in place due to the risk of vein injury or hemorrhage.The external catheter and the subcutaneous port were removed.There was no reported patient injury.
 
Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.The definitive root cause could not be determined based upon available information.Labeling review: a review of product labeling documentation (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: d4 (expiry date: 04/2023).H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TITANIUM LOW-PROFILE IMPLANTABLE PORT, BROVIAC SINGLE-LUMEN, 6.6F
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key17150483
MDR Text Key318096433
Report Number3006260740-2023-02493
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741025549
UDI-Public(01)00801741025549
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K050310
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 08/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number0602190
Device Catalogue Number0602190
Device Lot NumberREDV2237
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/22/2023
Initial Date FDA Received06/19/2023
Supplement Dates Manufacturer Received09/06/2023
Supplement Dates FDA Received09/08/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexMale
-
-